Fulgent Genetics (FLGT) Equity Income (2017 - 2020)
Fulgent Genetics (FLGT) posted Equity Income of -$687000.0 for Q4 2019, up 23.58% sequentially from -$899000.0 in Q3 2019, and up 11.24% YoY from -$617581.9 in Q4 2018.
Fulgent Genetics (FLGT) Equity Income (2017 - 2020) Analysis & Trends
Fulgent Genetics has reported Equity Income for 4 years, with the latest figure at -$687000.0 in Q4 2019.
- Quarterly Equity Income rose 11.24% year-over-year to -$687000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$3.0 million (down 7.28% YoY) and the FY2019 annual result came in at -$3.0 million, up 2.97% from the prior year.
- Equity Income climbed to -$687000.0 in Q4 2019 per FLGT's latest filing, from -$899000.0 in the prior quarter.
- Over five years, Equity Income peaked at $7000.0 in Q4 2016 and troughed at -$899000.0 in Q3 2019.
- A 4-year average of -$628625.0 and a median of -$688500.0 in 2018 frame the typical range for Equity Income.
- The sharpest annual moves came in 2017 and 2019: Equity Income plunged 11785.71% in 2017, then climbed 11.24% in 2019.
- Over 4 years, Equity Income stood at $7000.0 in 2016, then slumped by 11785.71% to -$818000.0 in 2017, then advanced by 5.38% to -$774000.0 in 2018, then climbed by 11.24% to -$687000.0 in 2019.
- According to Business Quant data, Equity Income over the past three periods registered -$687000.0, -$899000.0, and -$774000.0 for Q4 2019, Q3 2019, and Q4 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -15.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 17.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -6.20 Mn |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 143,000.00 |
| Sep 30, 2020 | -189,000.00 |
| Jun 30, 2020 | -193,000.00 |
| Mar 31, 2020 | -249,000.00 |
| Dec 31, 2019 | -174,000.00 |
| Sep 30, 2019 | -175,000.00 |
| Jun 30, 2019 | -149,000.00 |
| Mar 31, 2019 | -279,000.00 |
| Dec 31, 2018 | -234,000.00 |
| Sep 30, 2018 | -210,000.00 |
| Jun 30, 2018 | -246,000.00 |
| Mar 31, 2018 | -245,000.00 |
| Dec 31, 2017 | -247,000.00 |
| Sep 30, 2017 | -172,000.00 |
| Jun 30, 2017 | -105,000.00 |